Search Results - "Singer, C. F."

Pulmonary Hypertension Following the Use of Trastuzumab Biosimilars.

Authors: Ojo, Timi Cablay, Kory Emara, Neveen et al.

Source: Case Reports in Pulmonology. 5/4/2026, Vol. 2026, p1-4. 4p.

Author index to Volume 45.

Source: Histopathology. Dec2004, Vol. 45 Issue 6, p660-664. 5p.

Genetic Counselling, Testing, and Management of Hereditary Breast and Ovarian Cancer Syndrome in India: Updated Expert Consensus Recommendations from Indian Society of Medical and Pediatric Oncology.

Authors: Malhotra, Hemant Pramanik, Raja Srinivas, Sujay et al.

Source: Indian Journal of Medical & Paediatric Oncology. Jun2025, Vol. 46 Issue 3, p233-252. 20p.

The Impact of Pilates Exercise on the Overall Health of Patients With Breast Cancer: A Systematic Review and Meta-Analysis.

Authors: Ryu, Seulgi Im, Ahram Kim, Soyeon

Source: Oncology Nursing Forum. May2026, Vol. 53 Issue 3, p1-11. 11p.

Impact of Adjuvant Chemotherapy on Survival Outcomes in Intermediate‐ and High‐Risk ER+/HER2− Breast Cancer Stratified by Genomic Profiling: A Meta‐Analysis.

Authors: Seabrook, Max Navas, Ahamed S. M. Francis, Hannah-Maria et al.

Source: International Journal of Breast Cancer. 4/6/2026, Vol. 2026, p1-10. 10p.

Guestimating Molecular Subtyping of Breast Cancer by Ki67 in the Era of Artificial Intelligence.

Authors: Connolly, Catherine E. Sgier, Barbara Padberg Masser, Regina et al.

Source: International Journal of Breast Cancer. 1/2/2026, Vol. 2025, p1-9. 9p.

Women's Health Beliefs and Intention to Use Chemoprevention for Breast Cancer.

Authors: Keller, Kristin G. Toriola, Adetunji T. Kraenzle Schneider, Joanne

Source: Oncology Nursing Forum. Sep2023, Vol. 50 Issue 5, p611-623. 13p.

Modifiable and Nonmodifiable Risk Factors for Breast Cancer: A Comprehensive Scoping Review.

Authors: Momenimovahed, Zohre Shahabinia, Zahra Allahqoli, Leila et al.

Source: International Journal of Breast Cancer. 4/7/2026, Vol. 2026, p1-17. 17p.

23Na-MRI for Breast Cancer Diagnosis and Treatment Monitoring: A Scoping Review.

Authors: Smith, Taylor Chau, Minh Sims, Jordan et al.

Source: Bioengineering (Basel). Feb2025, Vol. 12 Issue 2, p158. 17p.

Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2‐Positive Breast Cancer.

Authors: Jia, Miaomiao Yang, Haibo Pan, Lihui et al.

Source: Breast Journal. 10/10/2024, Vol. 2024, p1-8. 8p.

Preclinical and clinical evaluation through serial colonoscopic evaluation of neratinib‐induced diarrhea in HER2‐positive breast cancer—A pilot study.

Authors: Bowen, Joanne Braga, Sofia Zotto, Valeria Dal et al.

Source: Physiological Reports. Aug2024, Vol. 12 Issue 16, p1-12. 12p.

Comparison of BRCA1 Gene Expression and CA15‐3 Tumor Marker Level in Different Stages of Breast Cancer.

Authors: Soltani Irdmusa, Negar Bashi Zadeh Fakhar, Haniyeh Heshmati, Masoumeh et al.

Source: Breast Journal. 8/12/2024, Vol. 2024, p1-7. 7p.

Online Provision of BRCA1 and BRCA2 Health Information: A Search Engine Driven Systematic Web-Based Analysis.

Authors: Gootzen, Tamar A. Kalra, Ashwin Sarig, Katrina et al.

Source: Cancers. Jul2024, Vol. 16 Issue 13, p2324. 17p.

Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2‐Positive Breast Cancer.

Authors: Otoya, Iris Valdiviezo, Natalia Morante, Zaida et al.

Source: International Journal of Breast Cancer. 6/22/2024, Vol. 2024, p1-12. 12p.

Evaluation of family history in individuals with heterozygous BRCA pathogenic variants diagnosed with breast or ovarian cancer in a single center in Italy.

Authors: Negri, Serena De Ponti, Elena Sina, Federica Paola et al.

Source: Molecular Genetics & Genomic Medicine. Dec2022, Vol. 10 Issue 12, p1-9. 9p.

Therapeutic Potential of Withaferin-A and Propolis Combinational Drug Therapy for Breast Cancer: An In Vivo Interpretation for Validating the Antiproliferative Efficacy and Ameliorative Potential in Benzo[a]pyrene-Induced Breast Metastasis.

Authors: T. S., Meghalatha Suresh, Arumugam Natrajan, Muninathan et al.

Source: Journal of Chemistry. 5/14/2024, Vol. 2024, p1-12. 12p.

Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers.

Authors: Faermann, Renata Friedman, Eitan Kaidar-Person, Orit et al.

Source: Breast Journal. 10/27/2022, Vol. 2022, p1-7. 7p.

Germline BRCA2 Mutation and Lynch Syndrome in a Patient With Multiple Primary Malignancies.

Authors: Puglisi, Morgan M. Dziarnowski, Natasha N. Baralo, Bohdan et al.

Source: Case Reports in Oncological Medicine. 8/20/2025, Vol. 2025, p1-7. 7p.

Disease-Free Survival after Breast Conservation Therapy vs. Mastectomy of Patients with T1/2 Breast Cancer and No Lymph Node Metastases: Our Experience.

Authors: Fanizzi, Annarita Ressa, Maurizio Cosmo Gatta, Gianluca et al.

Source: Applied Sciences (2076-3417); Nov2021, Vol. 11 Issue 21, p9800, 10p

Exploring New Frontiers: Alternative Breast Cancer Treatments Through Glycocalyx Research.

Authors: Gorodetska, Ielizaveta Samusieva, Anastasiia Lahuta, Tetiana et al.

Source: Breast Journal. 5/22/2025, Vol. 2025, p1-22. 22p.